MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thomas Thum(Medizinische Hochschule Hannover), Stefan Engelhardt(Heidelberg University), Andreas Rosenwald(Comprehensive Cancer Center Mainfranken), Jonathan D. Licht(University of Florida Health), Thomas Tuschl(Howard Hughes Medical Institute), Sara H. Rouhanifard(Northeastern University), John T. R. Pena(Rockefeller University), Wolfgang Rottbauer(Universität Ulm), Martina U. Muckenthaler(Heidelberg University), Markus Bussen(University of California, San Francisco), Jürgen Soutschek(Regulus Therapeutics (United States)), Paolo Galuppo, Stefan Frantz(Universitätsklinikum Würzburg), Stephan Kissler(Joslin Diabetes Center), M. Castoldi(Istituto Nazionale di Fisica Nucleare, Laboratori Acceleratori e Superconduttività Applicata), M. Albert Basson(King's College London), Jan Fiedler(Medizinische Hochschule Hannover), Steffen Just(Universität Ulm), Thomas Fischer(Deutsche Forschungsgemeinschaft), Victor Koteliansky(Centre National de la Recherche Scientifique), Carina Gross(Deutsche Forschungsgemeinschaft), Gail R. Martin(University of California, San Francisco), Johann Bauersachs(Medizinische Hochschule Hannover)
Cited by 2,355
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k